Akil Benjamin, DO
Interventional Pain Medicine · Westminster, MDNPI 1558573477
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 209 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 32 manufacturers reported payments, led by Abbott at 25.4% of the total.
Across 209 payments — averaging $31.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$2K
- Nevro Corp.$845
- Globus Medical$503
- Boston Scientific$490
- Collegium Pharmaceutical, Inc.$416
- Medtronic$365
- plus $2K from 26 others
What the payments were for
- Food & beverage$6,619100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 33 | $1,684 |
| Nevro Corp. | 26 | $845 |
| Globus Medical | 8 | $503 |
| Boston Scientific | 12 | $490 |
| Collegium Pharmaceutical, Inc. | 20 | $416 |
| Medtronic(2 entities) | 7 | $365 |
| Saluda Medical Americas, Inc. | 12 | $354 |
| Vertos Medical, Inc. | 13 | $306 |
| Pfizer | 13 | $261 |
| Scilex Pharmaceuticals Inc. | 15 | $217 |
| Flowonix Medical Incorporated | 1 | $180 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 8 | $150 |
| Si-bone, Inc. | 2 | $147 |
| Electronic Waveform Lab, Inc. | 6 | $107 |
| Averitas Pharma Inc. | 3 | $66 |
| Biotronik NRO, Inc. | 3 | $63 |
| Novartis | 4 | $63 |
| Vertex | 3 | $48 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $45 |
| Lundbeck LLC | 2 | $43 |
| Kowa Pharmaceuticals America, Inc. | 2 | $35 |
| Daiichi Sankyo Inc. | 2 | $34 |
| Amgen | 2 | $28 |
| AbbVie(2 entities) | 2 | $27 |
| Tonix Medicines, Inc. | 1 | $22 |
| Amneal Pharmaceuticals LLC | 1 | $22 |
| Kaleo, Inc. | 1 | $20 |
| Arbor Pharmaceuticals, Inc. | 1 | $19 |
| Almatica Pharma LLC | 1 | $16 |
| Johnson & Johnson | 1 | $16 |
| Biodelivery Sciences International, Inc. | 1 | $15 |
| Shionogi Inc | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Proclaim Family of SCS IPGs$414
- PROCLAIM$403
- Senza$401
- Omnia$340
- Prometra II$180
- ETERNA$133
- INTELLIS ADAPTIVESTIM$128
- Evoke$122
- iFuse Implant$115
- mild Device Kit$113
- WAVEWRITER ALPHA$104
- Proclaim DRG IPG$102
- WaveWriter Alpha Prime 16$101
How this compares
$6,619 in reported general payments places this provider in the 60th percentile of 56 interventional pain medicine providers in Maryland.
See all interventional pain medicine providers in Maryland →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OxycontinOxycodone Hcl | 21 | $7,038 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 142 | $4,861 |
| Oxycodone Hcl | 147 | $2,525 |
| Gabapentin | 192 | $2,169 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 120 | $2,022 |
| Morphine Sulfate ErMorphine Sulfate | 72 | $1,236 |
| Lidocaine | 19 | $999 |
| Naloxone Hcl | 13 | $940 |
| Tramadol Hcl ErTramadol Hcl | 14 | $921 |
| Tizanidine Hcl | 69 | $637 |
| Pregabalin | 37 | $533 |
| Cyclobenzaprine Hcl | 46 | $496 |
| Hydromorphone Hcl | 42 | $409 |
| Morphine Sulfate | 20 | $392 |
| Tramadol Hcl | 76 | $371 |
Paid to pharmacies, not to this prescriber.
Other interventional pain medicine in Westminster
- Mark ColemanPikesville$1.3M
- Marc LoevRockville$318K
- Anish PatelFrederick$311K
- Aneesh SinglaSalisbury$167K
- Charles SimmonsAnnapolis$62K
- Ali El-MohandesHagerstown$57K
- Michael WongBel Air$31K
- Anna IrwinBethesda$30K
- Dontese NicholsonBaltimore$27K
- Rajesh JariNottingham$26K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.